Target intelligence / Profile preview

Pathogenic microorganisms – epithelial adhesion sites

Molecular classification
Receptor, Cell adhesion molecule, Glycan, Other
01

Overview

Pathogenic microorganisms – epithelial adhesion sites refers to the diverse array of molecular structures on the surface of host epithelial cells that serve as docking points for bacteria, viruses, and other pathogens. These sites typically include cell surface receptors such as Intercellular Adhesion Molecule-1 (ICAM-1) and Platelet-Activating Factor Receptor (PAFR), cell adhesion molecules like integrins and cadherins, and various glycans including sialic acid and heparan sulfate. Pathogens utilize specialized surface proteins, known as adhesins or attachment proteins, to recognize and bind to these specific host sites, which is a critical first step in colonization, tissue invasion, and the establishment of infection. Therapeutic strategies targeting these sites aim to prevent or treat infections by blocking the initial attachment phase. This can be achieved through competitive inhibitors like D-mannose for urinary tract infections, monoclonal antibodies that mask host receptors or pathogen adhesins, or probiotics that occupy these sites to exclude pathogens. Unlike traditional antibiotics, anti-adhesion therapies often exert less selective pressure for resistance and can be used as prophylactic or adjunctive treatments for various infectious diseases, particularly in the respiratory and gastrointestinal tracts.

Other names
Host-pathogen adhesion receptorsEpithelial docking sitesMicrobial attachment sitesPathogen-host interfaceEpithelial adhesion molecules
02

Mechanism of action

Competitive inhibition of pathogen binding to host epithelial receptors, steric hindrance of the adhesion interface, and downregulation of host receptor expression to prevent colonization and invasion.

03

Biological functions

Cell adhesionInfectionPathogen entryBarrier functionSignal transduction
04

Disease associations

InfectionInflammationRespiratory diseaseGastrointestinal diseaseUrogenital infection
05

Safety considerations

Disruption of commensal microbiotaPathogen adaptation and use of alternative adhesion mechanismsInterference with normal host cell-cell adhesion and signalingPotential for systemic inflammatory response if host receptors are blocked
06

Interacting drugs

D-Mannose

6 more in the full profile.

07

Biomarkers

Pathogen load (e.g., viral titer, bacterial CFU)ICAM-1 expression levelsPAFR expression levelsPro-inflammatory cytokine levels (e.g., IL-8)

Beyond the preview

Go deeper on Pathogenic microorganisms – epithelial adhesion sites.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic microorganisms – epithelial adhesion sites.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call